SaeedSadeghiMD
Oncology • Santa Monica, CAHematologic Oncology
Professor, Medicine, UCLA School of Medicine
Dr. Sadeghi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2020 Santa Monica Boulevard
Suite 230
Santa Monica, CA 90404Phone+1 310-829-5471Fax+1 310-582-6294
Summary
- Dr. Saeed Sadeghi is an oncologist in Santa Monica, CA and is affiliated with multiple hospitals in the area, including Ronald Reagan UCLA Medical Center and UCLA Medical Center-Santa Monica. He received his medical degree from Saint Louis University School of Medicine and has been in practice 18 years. He also speaks multiple languages, including Farsi and French. He specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and hodgkin's lymphoma.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1999 - 2002
Saint Louis University School of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2000 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma Start of enrollment: 2014 Jul 23
- This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer Start of enrollment: 2017 May 04
Publications & Presentations
PubMed
- 444 citationsPhase II Study of BGJ398 in Patients With FGFR-Altered Advanced CholangiocarcinomaMilind Javle, Maeve A. Lowery, Rachna T. Shroff, Karl Heinz Weiss, Christoph Springfeld
Journal of Clinical Oncology. 2017-11-28 - 122 citationsPurification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoringNa Sun, Yi-Te Lee, Ryan Y. Zhang, Rueihung Kao, Pai-Chi Teng
Nature Communications. 2020-09-07 - 59 citationsInfigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF 301 trialShalini Makawita, Ghassan K. Abou-Alfa, Sameek Roychowdhury, Saeed Sadeghi, Ivan Borbath
Future Oncology. 2020-06-25
Professional Memberships
- Member
Other Languages
- Farsi, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
